Crowdfunding
Doorway and SeedBlink Sign a Partnership to Give More Investment Options to Investors
The agreement with SeedBlink is part of Doorway’s international expansion process, which has already partnered with OurCrowd – a global online venture capital platform named the most active venture capital investor in Israel by Pitchbook – and opened an office in Brussels, with a local team dedicated to developing the European market
Italian equity crowdfunding platform for venture capital investment Doorway and the Romanian company SeedBlink, a European venture investment platform specializing in technology, have signed a strategic partnership to provide their investors with a unique channel of access to investments in international hi-tech startups and scale-ups.
SeedBlink enables private investors to fund high-end hi-tech startups and scale-ups across Europe. Founded in Romania and already licensed throughout Europe under the new European regulation, the platform has more than 70,000 private investors and has raised €60 million in the past three years.
In August 2022, SeedBlink acquired the historic Dutch platform Symbid, one of the first equity crowdfunding platforms in Europe, founded in 2011.
The partnership will be able to provide users of both platforms-private clients, financial advisors, private bankers, family offices, and wealth managers-with an evolving portfolio of high-profile deals.
SeedBlink CEO Carmen Sebe said: “The growth of the European tech sector is promising, but the fragmentation of the market between countries, each with its own legal system, makes investing across borders complicated. So the challenge is to build a European network through local representation in each country. Doorway’s leadership in Italy will offer our investors unique access to high-potential investments with Italian DNA.”
If you want to find more details about the partnership between Doorway and SeedBlink, download for free our companion app. The Born2Invest mobile app brings you the most important business news of the day so you can stay on top of the market.
The content and benefits of the partnership between Doorway and SeedBlink
Based on the signed partnership, Doorway’s investor community will have access to deals selected by Seedblink in the international market and vice versa. This will facilitate pan-European investments by consolidating the financial infrastructure available to technology SMEs.
The partnership between SeedBlink and Doorway will provide investors with a portfolio of selected and evolving investment opportunities, in advanced or follow-up rounds, with rapid exit prospects and often already funded by international Venture Capital funds.
With access through SeedBlink to a deal-flow of high-profile European technology-driven realities and Doorway’s local expertise, the partnership will offer the opportunity to create a value proposition for investors with a portfolio of innovative start-ups with high growth potential.
Doorway’s internationalization
The agreement with Seedblink is part of Doorway’s international expansion process, which has already partnered with OurCrowd – a global online venture capital platform named the most active venture capital investor in Israel by Pitchbook – and opened an office in Brussels, with a local team dedicated to developing the European market
Doorway CEO Antonella Grassigli said: “We are excited to partner with SeedBlink, Europe’s leading venture capital platform specializing in technology. This partnership will provide Doorway’s investor community with access to innovative technology startups and scale-ups selected by Seedblink.”
__
(Featured image by ccfb via Pixabay)
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in Crowdfunding buzz, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions, or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
-
Fintech2 weeks ago
Fintech Company Satispay Raises 60 Million Euros Led by Addition
-
Biotech3 days ago
ATB Therapeutics Raises €54 Million and Attracts a Pharmaceutical Giant
-
Fintech1 week ago
LAKPA Strengthens Its Offering in Mexico with Model Portfolios from JP Morgan AM
-
Biotech19 hours ago
21 Invest Launches the First Fund Dedicated to the Healthcare Sector, with a Closing of 70 Million and a Target of 150 Million